912669-58-0Relevant articles and documents
Aryl hetero ring-substituted aromatic compound (by machine translation)
-
Paragraph 0225; 0227, (2020/09/17)
[Problem] β - lactamase inhibiting action in a new compound. (1A) or (1b) or a compound represented by the formula [a] to pharmaceutically acceptable salts. [(1A) (1b) and in the formula, g is, O, etc. S; X is, a hydroxyl group, an alkoxy group such as C1
USE OF SPIRO-OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS
-
, (2010/07/10)
This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment and/or prevention of hypercholesterolemia, benign prostatic hyperplasia, pruritis and cancer.
SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
-
Page/Page column 140, (2010/11/24)
This invention is directed to spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of preparing and using the compounds are also disclosed.